News
US military uses genetic engineering to develop “living tripwires” for submarines
The US Department of Defense (DoD) is investing $45 million dollars in a tri-service effort that focuses on synthetic biology (SynBio) for use in military technologies. This interdisciplinary scientific field primarily involves altering the genetic makeup of organisms to achieve specific behavior, and the military wants in on its potential applications. By uniting SynBio experts within the US Air Force, Army, and Navy, DoD officials hope to develop serious capabilities for use throughout the military’s branches.
The long form name of this project is the Applied Research for the Advancement of Science and Technology Priorities Program on Synthetic Biology for Military Environments, and the mission is obvious from its title alone. While still in the early research stages, engineering organisms could provide numerous tools with direct defense applications.
For example, organisms engineered to change their colors based on their environment could be used as living camouflage, and medications infused with protective microbes could help service member survival in tough conditions. However, it’s perhaps the US Naval Research Laboratory (NRL) in Washington DC that may hold the relevant interest in developing SynBio capabilities due to the marine environment potentials it holds.
Above the water, engineered self-repairing organisms could spell out self-healing paint for ships and aircraft carriers, cutting billions from the US Navy’s fleet maintenance costs. Even more important for defense needs, though, are the modified organisms that could help the branch’s deep water operations, i.e., submarines. By modifying the environmental response of naturally present organisms, naval defense could have a new type of radar at their disposal.
An abundant seawater-native bacteria with “clinging” properties called Marinobacter is a prime candidate for the DoD’s purposes. Specifically, the organism could be genetically engineered to react to certain types of molecules that aren’t naturally occurring in the ocean, such as diesel fuel or human DNA, and then spread into targeted environments for monitoring. This reaction could perhaps be the release of an electron, thus creating an electrical signal which nearby drones could pick up and transmit where necessary. The ability to detect non-friendly submarines is the key capability the researchers are aiming to achieve, the bacteria acting as “living tripwires.”
The field of synthetic biology is not new in the civilian world. In fact, consumer products currently exist based on it, such as bio fuels, soaps, cleaners, food additives, and a variety of industrial and manufacturing products. One of the challenges of bringing this type of technology to the field for military use is making the modified organisms tough enough to endure the environments needed.
“If you want to move a biological bio-based sensor to the field you try to ruggedize those organisms. You try to protect them…[and]…increase their longevity in these harsh environments,” explained Dimitra Stratis-Cullum, the lead of U.S. Army Research Laboratory biomaterials team, in a recent forum hosted by the Johns Hopkins University Applied Physics Laboratory.
The current genetic research being conducted in SynBio has demonstrated that the genes of E. coli bacteria can be manipulated to express properties relevant to the larger goal of underwater sensing. However, the significant differences between the E. Coli and the types of organisms natural to deep water environments, such as Marinobacter, can be compared to the differences between mice and humans.
The initial point really is to either prove that the desired outcome is possible or collect data to assist in that effort. In other words, there’s still a lot of work to be done, but making the effort a priority, such as what the Navy’s done with its “Task Force Ocean” mission aimed at strengthening partnerships within academia and the private sector regarding Navy-relevant ocean science, is a focused step in the right direction for the military to achieve its goals in SynBio.
Tesla stock (NASDAQ: TSLA) endured one of its sharpest single-day declines in years on July 23, tumbling approximately 14.5 percent and closing near $320 after opening the session around $374. The drop erased more than $140 billion in market value amid heavy trading volume and left the shares at multi-week lows.
The sell-off followed the company’s second-quarter 2026 results, released the previous evening. Tesla reported record revenue of $28.2 billion, up 26 percent year over year, driven by a Q2-record 480,126 vehicle deliveries. Energy storage deployments also rose strongly.
Tesla (TSLA) Q2 2026 earnings results: miss on EPS, beat on revenue
Yet profitability disappointed sharply. Operating income fell 57 percent to $398 million, compressing the operating margin to just 1.4 percent. Non-GAAP earnings per share came in at $0.33, well below the roughly $0.53 analysts had expected. Free cash flow turned negative by $1.1 billion as capital expenditures surged 142 percent to $5.8 billion, largely tied to accelerated spending on artificial intelligence, robotics, and autonomous systems.
The losses on capex were expected, as Tesla said it would be spending heavily in 2026.
Investors also reacted to lingering uncertainty surrounding key product timelines. During the Earnings Call, management reiterated ambitions for Robotaxi deployment and the Optimus humanoid robot, but offered limited new concrete milestones, renewing questions about execution pace that have long accompanied Tesla’s ambitious roadmap.
The magnitude of the decline places it among Tesla’s more severe one-day percentage losses since its 2010 initial public offering. Historically, the two largest single-day drops (split-adjusted) remain September 8, 2020, when shares fell 21.1 percent amid broader market volatility and valuation concerns, and January 13, 2012, with a 19.3 percent plunge during the company’s early growth struggles.
Other notable declines include an 18.6 percent drop on March 16, 2020, at the onset of pandemic-related market turmoil. Thursday’s move ranks roughly ninth on the all-time list but stands out as the steepest in more than a year.
Despite the short-term pain, Tesla’s long-term trajectory has repeatedly recovered from such volatility. The latest results underscore both the strength of its core automotive and energy businesses and the near-term costs of heavy investment in next-generation technologies.
Elon Musk clapped back at France’s decision to withhold the approval for Tesla’s Full Self-Driving (FSD) Supervised system, projecting a clear and blunt message to French Transport Minister Phillippe Tabarot, after he publicly rejected the technology in its current form.
Tabarot outlines several concerns with Tesla Full Self-Driving in a detailed video statement, where he said, “The safety trade-offs are not yet sufficient to authorize it as it currently stands,” he said. He emphasized that FSD is not a true self-driving system and that the driver remains fully responsible.
Key issues Tabarot also brought up included allowing speeding when surrounding traffic exceeds limits and what he believes are insufficient guarantees of driver attention during complex urban maneuvers such as lane changes, intersections, and roundabouts.
Delaying the approval of FSD in France will cost lives
— Elon Musk (@elonmusk) July 22, 2026
While acknowledging technological progress and France’s support for autonomous innovation, Tabarot stressed that deployment must prioritize road safety. He noted ongoing technical discussions with Tesla, the Netherlands, and other European partners, with further ecosystem meetings planned for the fall.
Musk’s rebuke highlights the human cost of regulatory caution. Tesla’s latest safety reports provide compelling data supporting accelerated adoption. In the most recent 12-month period, vehicles using FSD (Supervised) recorded one major collision per approximately 5.1 million miles driven, dramatically better than the U.S. national average of one crash per 698,000 miles.
Even Tesla vehicles driven manually with active safety features outperform the average by a wide margin. These figures come from billions of real-world miles of telemetry, showing FSD vehicles involved in far fewer incidents than both manual Teslas and the broader U.S. fleet.
Critics argue Tesla’s comparisons require careful scrutiny regarding reporting thresholds and fleet demographics, yet the data consistently positions FSD as a potential lifesaver. With road fatalities remaining a leading cause of death worldwide, Musk contends that proven safer technology should not face prolonged bureaucratic hurdles.
France’s measured approach reflects the broader European regulatory caution, which many, especially Musk, have been critical of in the past. However, as autonomous systems from Tesla and competitors like Waymo demonstrate superior safety in independent studies, pressure is mounting for harmonized approvals.
Musk’s warning carries the belief that every month of delay may equate to avoidable tragedies on European roads.
In a striking revelation that underscores the lucrative crossover between Big Tech and space exploration, Alphabet Inc., Google’s parent company, disclosed a massive $94.1 billion equity stake in SpaceX following the rocket company’s blockbuster initial public offering earlier this year.
The disclosure came in Alphabet’s quarterly filing, marking the first time the long-held private investment has been publicly valued at market prices. Google was an early backer, investing alongside Fidelity in 2015 with roughly $500-900 million at a time when SpaceX was valued around $12 billion.
That bet has delivered extraordinary returns, roughly a hundredfold, transforming a strategic play on satellite internet and launch capabilities into one of Alphabet’s largest assets.
Google, $GOOGL, has said they hold $94 billion in SpaceX, $SPCX, shares after IPO.
— unusual_whales (@unusual_whales) July 23, 2026
Of the total holding, approximately $80 billion remains subject to short-term post-IPO lockup restrictions, preventing near-term sales. An additional $14.1 billion faces longer-term restrictions, extending into the third quarter of 2027. This structure limits immediate liquidity but protects against market volatility as SpaceX transitions into public trading.
The SpaceX position contributed significantly to gains in Alphabet’s broader investment portfolio, which also includes a major stake in AI leader Anthropic. Combined, these holdings helped drive nearly $100 billion in investment gains during the second quarter, providing a substantial boost to net income amid ongoing AI spending pressures.
Analysts view the disclosure as validation of Alphabet’s venture strategy beyond its core search and cloud businesses. The investment aligns with deeper ties, including reported multi-billion-dollar deals for AI computing capacity on SpaceX infrastructure. As SpaceX advances Starship flights, Starlink expansion, and ambitious Mars goals under Elon Musk, Google’s stake positions it to benefit from the commercialization of space.
For Alphabet, the windfall highlights how patient, forward-looking bets in transformative sectors can yield outsized rewards. While lockups temper short-term impact, the holding cements SpaceX as a cornerstone of Alphabet’s diversified portfolio in an era where aerospace, AI, and connectivity increasingly intersect. Investors will watch closely as restrictions lift and SpaceX’s public performance unfolds.
Tesla stock tumbles after earnings, one of its sharpest single-day declines
Elon Musk is not happy about this Tesla Full Self-Driving approval delay
